Brain+ A/S Sustainability Reports
Brain+ A/S is a digital health company specializing in the development of non-pharmacological digital therapeutics for dementia and Alzheimer's disease. Its flagship product is designed to support Cognitive Stimulation Therapy (CST) for patients.
Sector: Technology & telecommunications
Country: Denmark
Exchange: Nasdaq Copenhagen
LEI: 9845007708709CEGD845
FIGI: BBG007VDTB87
1 reports from 2024 to 2024
